Health ❯Pharmaceuticals

Drug Development

Drug Development Pharmaceuticals Pharmacology Drug Development Clinical Trials Neurology Drug Development Weight Management FDA Food and Drug Administration

Noom Introduces Personalized Microdoses of Compounded Wegovy Ahead of FDA Deadline

The telehealth company aims to offer affordable, side-effect-conscious alternatives as FDA regulations tighten on compounded weight-loss drugs.

Trump Orders U.S. Drug Prices Tied to Lowest OECD Rates, Sparking Concerns Over Global Impact

Researchers Identify Broad-Spectrum Inhibitors for Malaria Parasite's Key Protein Family

Study Unveils Acetaminophen’s Pain Relief Mechanism After Decades of Mystery

Novo Nordisk Partners with Septerna in $2.2 Billion Deal for Oral Obesity Therapies

Scientists Unveil AI-Driven Workflow for Designing Bespoke Enzymes

WEHI Scientists Unveil Small Molecule That Prevents Neuron Death

Psilocybin Pilot Study Shows Weeks-Long Symptom Relief in Parkinson’s Patients

AstraZeneca Reports Q1 Growth and Expands US Investments Amid Regulatory Challenges

Pharma CEOs Urge EU to Reform Pricing Policies as U.S. Investments Surge

Senolytic Drugs Clear 'Zombie Cells,' Offer New Hope for Chronic Back Pain Treatment

Novo Nordisk Seeks FDA Approval as Eli Lilly's Weight-Loss Pill Advances

FDA Launches Immediate Plan to Replace Animal Testing with Human-Relevant Methods

Pfizer Halts Development of Oral Weight-Loss Pill After Liver Injury

FDA Launches Roadmap to Phase Out Animal Testing in Drug Development

Nitisinone Identified as Promising Mosquito-Killing Tool in Malaria Fight

FDA Approves First New Oral Antibiotic for UTIs in Over 20 Years

Novo Nordisk Acquires Chinese Obesity Drug After CagriSema Trial Disappointment

Experimental Drug Shows Potential to Delay Alzheimer's Onset by 50%

Study Suggests Long-Term Anti-Amyloid Therapy May Delay Early-Onset Alzheimer’s